SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K/A
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): October 31, 2005
Commission file number 001-12215
Quest Diagnostics Incorporated
1290 Wall Street West
Lyndhurst, NJ 07071
(201) 393-5000
Delaware
(State of Incorporation)
16-1387862
(I.R.S. Employer Identification Number)
Quest Diagnostics Incorporated hereby amends Item 2.01 of its Current Report on Form 8-K (Date of Report: October 31, 2005) as follows:
The financial statements and proforma combined financial information required to be filed pursuant to Rule 3-05 of Regulation S-X and Article 11 of Regulation S-X under the Securities Act of 1933, as amended, are included in this current report on Form 8-K under Item 9.01.
Item 9.01. Financial Statements and Exhibits
|
Exhibits |
|
|
99.1 |
Financial statements of businesses acquired. The financial statements of LabOne, Inc. as of December 31, 2004 and 2003 and for the three years ended December 31, 2004, 2003 and 2002 are included as Exhibit 99.1. |
|
|
99.2 |
Financial statements of businesses acquired. The financial statements of LabOne, Inc. as of September 30, 2005 and December 31, 2004 and for the three and nine months ended September 30, 2005 and 2004 are included as Exhibit 99.2. |
99.3 |
Pro forma financial information. The unaudited pro forma combined balance sheet of Quest Diagnostics as of September 30, 2005 and the unaudited pro forma combined statements of operations of Quest Diagnostics for the nine months ended September 30, 2005 and the year ended December 31, 2004 are included as Exhibit 99.3. |
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
January 17, 2006 |
QUEST DIAGNOSTICS INCORPORATED
|
By: |
/s/ Robert A. Hagemann |
Robert A. Hagemann
Senior Vice President and Chief Financial Officer